Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-09-056863
Filing Date
2009-12-15
Accepted
2009-12-15 18:00:05
Documents
2
Period of Report
2009-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd259451.html 3  
1 FORM 3 rrd259451.xml 3 10337
2 POA-WHEELER rrd232185_262334.htm EX-24. 3820
  Complete submission text file 0001181431-09-056863.txt   16107
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 8001 ARISTA PLACE, STE 200 BROOMFIELD CO 80021
Business Address
Wheeler Patrick M (Reporting) CIK: 0001478297 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 091242766